CompletedPhase 1NCT03731715

Carisbamate in Adult & Pediatric Subjects With Lennox-Gastaut Syndrome

Studying Lennox-Gastaut syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
SK Life Science, Inc.
Principal Investigator
Marc Kamin, MD
SK Life Science, Inc.
Intervention
Carisbamate(drug)
Enrollment
18 enrolled
Eligibility
2 years · All sexes
Timeline
20192022

Study locations (7)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03731715 on ClinicalTrials.gov

Other trials for Lennox-Gastaut syndrome

Additional recruiting or active studies for the same condition.

See all trials for Lennox-Gastaut syndrome

← Back to all trials